These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2888212)

  • 1. Implications of the consensus workshop on the evaluation of maternal and developmental toxicity.
    Kimmel GL; Kimmel CA; Francis EZ
    Teratog Carcinog Mutagen; 1987; 7(3):329-38. PubMed ID: 2888212
    [No Abstract]   [Full Text] [Related]  

  • 2. Consensus workshop on the evaluation of maternal and developmental toxicity work group II report: study design considerations.
    Palmer AK; Kavlock RJ
    Teratog Carcinog Mutagen; 1987; 7(3):311-9. PubMed ID: 2888210
    [No Abstract]   [Full Text] [Related]  

  • 3. Consensus workshop on the evaluation of maternal and developmental toxicity work group I report: end points of maternal and developmental toxicity.
    Skalko RG; Johnson EM
    Teratog Carcinog Mutagen; 1987; 7(3):307-10. PubMed ID: 2888209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of maternal and developmental toxicity. Proceedings of the consensus workshop. Rockville, Maryland, May 12-14, 1986.
    Teratog Carcinog Mutagen; 1987; 7(3):201-338. PubMed ID: 2888200
    [No Abstract]   [Full Text] [Related]  

  • 5. Consensus workshop on the evaluation of maternal and developmental toxicity work group III report: low dose extrapolation and other considerations for risk assessment--models and applications.
    Schwetz BA; Tyl RW
    Teratog Carcinog Mutagen; 1987; 7(3):321-7. PubMed ID: 2888211
    [No Abstract]   [Full Text] [Related]  

  • 6. Approaches to defining the relationship of maternal and developmental toxicity.
    Schardein JL
    Teratog Carcinog Mutagen; 1987; 7(3):255-71. PubMed ID: 2888205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs in the perinatal period: implications for the preterm infant.
    Rudd CC; Brazy JE
    Compr Ther; 1988 Dec; 14(12):30-7. PubMed ID: 3067970
    [No Abstract]   [Full Text] [Related]  

  • 8. Maternal toxicity in humans and animals: effects on fetal development and criteria for detection.
    Khera KS
    Teratog Carcinog Mutagen; 1987; 7(3):287-95. PubMed ID: 2888207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pregnancy.
    Bogaert MC; Thiery M
    Eur J Obstet Gynecol Reprod Biol; 1983 Dec; 16(4):229-35. PubMed ID: 6370750
    [No Abstract]   [Full Text] [Related]  

  • 10. An overview of maternal toxicity and prenatal development: considerations for developmental toxicity hazard assessments.
    Chernoff N; Rogers JM; Kavlock RJ
    Toxicology; 1989 Dec; 59(2):111-25. PubMed ID: 2686096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teratogen update: fetal effects of indomethacin administration during pregnancy.
    Norton ME
    Teratology; 1997 Oct; 56(4):282-92. PubMed ID: 9408979
    [No Abstract]   [Full Text] [Related]  

  • 12. [Teratogenesis and medication induced fetal toxicity].
    Elefant E; Bavoux F
    Rev Prat; 2003 Nov; 53(17):1920-5. PubMed ID: 14722981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug distribution.
    Feldman S
    Med Clin North Am; 1974 Sep; 58(5):917-26. PubMed ID: 4607390
    [No Abstract]   [Full Text] [Related]  

  • 14. Maternal factors in developmental toxicity.
    DeSesso JM
    Teratog Carcinog Mutagen; 1987; 7(3):225-40. PubMed ID: 2888203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of adult toxicity in developmental versus prechronic toxicology studies.
    Schwetz BA; Moorman MP
    Teratog Carcinog Mutagen; 1987; 7(3):211-23. PubMed ID: 2888202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drugs and embryonic-fetal development].
    Siala Gaigi S; Lakhal M
    Tunis Med; 1991; 69(8-9):477-81. PubMed ID: 1759321
    [No Abstract]   [Full Text] [Related]  

  • 17. Study designs for the assessment of male-mediated developmental toxicity.
    Hales BF; Cyr DG
    Adv Exp Med Biol; 2003; 518():271-7. PubMed ID: 12817696
    [No Abstract]   [Full Text] [Related]  

  • 18. Developmental toxicity evaluation of orthovanadate in the mouse.
    Sanchez D; Ortega A; Domingo JL; Corbella J
    Biol Trace Elem Res; 1991 Sep; 30(3):219-26. PubMed ID: 1720642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ILSI/HESI maternal toxicity workshop summary: maternal toxicity and its impact on study design and data interpretation.
    Beyer BK; Chernoff N; Danielsson BR; Davis-Bruno K; Harrouk W; Hood RD; Janer G; Liminga UW; Kim JH; Rocca M; Rogers J; Scialli AR
    Birth Defects Res B Dev Reprod Toxicol; 2011 Feb; 92(1):36-51. PubMed ID: 21312321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A dilemma of using psychotropic drugs in pregnancy and breast feeding].
    Szajer K; KarakuĊ‚a H; Grzywa A
    Pol Merkur Lekarski; 2003 Sep; 15(87):273-7. PubMed ID: 14679856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.